Haibing Chen

Dr. Haibing Chen

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in Disease Models & Mechanisms
Verified
Journal Article
Open access
PDF file
MWMian Wu
Mian Wu
YMYiwen Ma
Yiwen Ma
XCXiaoting Chen
Xiaoting Chen
NLNan Liang
Nan Liang
SQShen Qu
Shen Qu
HCHaibing Chen
Haibing Chen
Epidemiological research has shown that elevated serum urate concentration is a risk factor for the development of kidney disease; however, the mechanisms underlying this process have not yet been elucidated. To examine the role of urate in the kidney, we used Wistar rats to functionally disrupt expression of urate oxidase (UOX) by using the CRISPR/Cas9 system. In comparison to wild-type (WT) rats, serum urate levels spontaneously and persistently increased in UOX-KO rats, without showing a significant decrease in survival rate. Architecture and function of the kidneys in UOX-KO rats were impaired. Injury to the kidney resulted in increased interstitial fibrosis, macrophage infiltration, increased expression of NLRP3 and IL-1β, and activation of multiple cell-signaling pathways associated with autophagy, such as AMPK, p38 MAPK, ERK and JNK pathways. Inhibition of autophagy with the PI3K inhibitor 3-MA abrogated the development of kidney damage and attenuated renal fibrosis, macrophage infiltration, and expression of NLRP3 and IL-1β in injured kidneys. In conclusion, the UOX-KO rat is a great model to study hyperuricemia-related diseases. Hyperuricemia-induced autophagy and NLRP3-dependent inflammation are critically involved in the development of renal damage and, therefore, highlight the inhibition of autophagy and inflammation in search of therapeutic strategies to treat uric acid nephropathy.

19 December 2015 in Diabetologia
Verified
Journal Article
Closed access
PDF file
SZShuzhi Zhao
Shuzhi Zhao
TLTao Li
Tao Li
JLJun Li
Jun Li
QLQianyi Lu
Qianyi Lu
CHChangjing Han
Changjing Han
ZZZhi Zheng
Zhi Zheng

8 April 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KGKaifeng Guo
Kaifeng Guo
JLJunxi Lu
Junxi Lu
YHYan Huang
Yan Huang
MWMian Wu
Mian Wu
LZLei Zhang
Lei Zhang
WJWeiping Jia
Weiping Jia
The overproduction of mitochondrial reactive oxygen species (ROS) plays a key role in the pathogenesis of diabetic nephropathy (DN). However, the underlying molecular mechanism remains unclear. Our aim was to investigate the role of PGC-1α in the pathogenesis of DN. Rat glomerular mesangial cells (RMCs) were incubated in normal or high glucose medium with or without the PGC-1α-overexpressing plasmid (pcDNA3-PGC-1α) for 48 h. In the diabetic rats, decreased PGC-1α expression was associated with increased mitochondrial ROS generation in the renal cortex, increased proteinuria, glomerular hypertrophy, and higher glomerular 8-OHdG (a biomarker for oxidative stress). In vitro, hyperglycemia induced the downregulation of PGC-1α, which led to increased DRP1 expression, increased mitochondrial fragmentation and damaged network structure. This was associated with an increase in ROS generation and mesangial cell hypertrophy. These pathological changes were reversed in vitro by the transfection of pcDNA3-PGC-1α. These data suggest that PGC-1α may protect DN via the inhibition of DRP1-mediated mitochondrial dynamic remodeling and ROS production. These findings may assist the development of novel therapeutic strategies for patients with DN.

2 October 2023 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
CZChuandi Zhou
Chuandi Zhou
XSXinping She
Xinping She
CGChufeng Gu
Chufeng Gu
YHYanan Hu
Yanan Hu
MMMingming Ma
Mingming Ma
ZZZhi Zheng
Zhi Zheng
Endothelial dysfunction is a critical and initiating factor of the vascular complications of diabetes. Inflammation plays an important role in endothelial dysfunction regulated by epigenetic modifications. N6-methyladenosine (m6A) is one of the most prevalent epigenetic modifications in eukaryotic cells. In this research, we identified an m6A demethylase, fat mass and obesity-associated protein (FTO), as an essential epitranscriptomic regulator in diabetes-induced vascular endothelial dysfunction. We showed that enhanced FTO reduced the global level of m6A in hyperglycemia. FTO knockdown in endothelial cells (ECs) resulted in less inflammation and compromised ability of migration and tube formation. Compared with EC Ftofl/fl diabetic mice, EC-specific Fto-deficient (EC FtoΔ/Δ) diabetic mice displayed less retinal vascular leakage and acellular capillary formation. Furthermore, methylated RNA immunoprecipitation sequencing (MeRIP-Seq) combined with RNA-Seq indicated that Tnip1 served as a downstream target of FTO. Luciferase activity assays and RNA pull-down demonstrated that FTO repressed TNIP1 mRNA expression by erasing its m6A methylation. In addition, TNIP1 depletion activated NF-κB and other inflammatory factors, which aggravated retinal vascular leakage and acellular capillary formation, while sustained expression of Tnip1 by intravitreal injection of adeno-associated virus alleviated endothelial impairments. These findings suggest that the FTO-TNIP1-NF-κB network provides potential targets to treat diabetic vascular complications.

16 March 2015 in Obesity
Verified
Journal Article
Closed access
PDF file
KGKaifeng Guo
Kaifeng Guo
JLJunxi Lu
Junxi Lu
HYHaoyong Yu
Haoyong Yu
FZFangya Zhao
Fangya Zhao
PPPan Pan
Pan Pan
WJWeiping Jia
Weiping Jia

1 July 2016 in Journal of Diabetes and its Complications
Verified
Journal Article
Closed access
KGKaifeng Guo
Kaifeng Guo
LZLei Zhang
Lei Zhang
FZFangya Zhao
Fangya Zhao
JLJunxi Lu
Junxi Lu
PPPan Pan
Pan Pan
WJWeiping Jia
Weiping Jia